InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-9.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by NARACHI MICHAEL, Director. Director active across 2 companies, notably Ultragenyx Pharmaceutical Inc.. In total, 8 reports have been logged. History available since 24 June 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations8 total
5,740 shares0Common StockSEC:0000950170-25-074665:0
5,345 shares0Common StockSEC:0000950170-24-075487:0
3,860 shares0Common StockSEC:0001209191-23-035688:0
3,300 shares0Common StockSEC:0001209191-22-039565:0
2,145 shares0Common StockSEC:0001209191-21-043538:0
2,145 shares0Common StockSEC:0001209191-21-043538
721 sharesCommon StockSEC:0001209191-16-095645:0
1,761 sharesCommon StockSEC:0001209191-16-095645:1
8 of 8 declarations
About NARACHI MICHAEL
Michael Narachi is a Director of Ultragenyx Pharmaceutical Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. His experience and skills in corporate governance are essential for guiding Ultragenyx Pharmaceutical Inc. in its growth and innovation objectives.
